These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 11229468)

  • 1. The appearance of U1 RNP antibody specificities in sequential autoimmune human antisera follows a characteristic order that implicates the U1-70 kd and B'/B proteins as predominant U1 RNP immunogens.
    Greidinger EL; Hoffman RW
    Arthritis Rheum; 2001 Feb; 44(2):368-75. PubMed ID: 11229468
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Further characterization and subcellular localization of Sm and U1 ribonucleoprotein antigens.
    Habets WJ; Berden JH; Hoch SO; Van Venrooij WJ
    Eur J Immunol; 1985 Oct; 15(10):992-7. PubMed ID: 2414112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A new conformational epitope generated by the binding of recombinant 70-kd protein and U1 RNA to anti-U1 RNP autoantibodies in sera from patients with mixed connective tissue disease.
    Murakami A; Kojima K; Ohya K; Imamura K; Takasaki Y
    Arthritis Rheum; 2002 Dec; 46(12):3273-82. PubMed ID: 12483732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Apoptotic U1-70 kd is antigenically distinct from the intact form of the U1-70-kd molecule.
    Greidinger EL; Foecking MF; Ranatunga S; Hoffman RW
    Arthritis Rheum; 2002 May; 46(5):1264-9. PubMed ID: 12115232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-Sm and anti-RNP antibodies.
    Migliorini P; Baldini C; Rocchi V; Bombardieri S
    Autoimmunity; 2005 Feb; 38(1):47-54. PubMed ID: 15804705
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies against small nuclear ribonucleoprotein components.
    van Venrooij WJ
    J Rheumatol Suppl; 1987 Jun; 14 Suppl 13():78-82. PubMed ID: 2956421
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blotting patterns of IgG anti-(U1)RNP antibodies in mixed connective tissue disease.
    Ghirardello A; Doria A; Vesco P; Vaccaro E; Bernardi C; Catani C; Fagiolo U; Gambari PF
    Rheumatol Int; 1996; 16(4):145-50. PubMed ID: 8961378
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Longitudinal fluctuation of antibodies to extractable nuclear antigens in systemic lupus erythematosus.
    Faria AC; Barcellos KS; Andrade LE
    J Rheumatol; 2005 Jul; 32(7):1267-72. PubMed ID: 15996063
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibody recognition of distinctly modified forms of the U1-70-kd antigen is associated with different clinical disease manifestations.
    Greidinger EL; Casciola-Rosen L; Morris SM; Hoffman RW; Rosen A
    Arthritis Rheum; 2000 Apr; 43(4):881-8. PubMed ID: 10765934
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Autoantibodies that stabilize U1snRNP are a significant component of human autoantibodies to snRNP and delay proteolysis of sm antigens in vitro.
    Satoh M; Akaogi J; Kuroda Y; Nacionales DC; Yoshida H; Yamasaki Y; Reeves WH
    J Rheumatol; 2004 Dec; 31(12):2382-9. PubMed ID: 15570638
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison between line immunoassay (LIA) and enzyme-linked immunosorbent assay (ELISA) for the determination of antibodies to extractable nuclear antigenes (ENA) with reference to other laboratory results and clinical features].
    Maclachlan D; Vogt P; Wu X; Rose L; Tyndall A; Hasler P
    Z Rheumatol; 2002 Oct; 61(5):534-44. PubMed ID: 12399881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-RNP immunity: implications for tissue injury and the pathogenesis of connective tissue disease.
    Keith MP; Moratz C; Tsokos GC
    Autoimmun Rev; 2007 Mar; 6(4):232-6. PubMed ID: 17317614
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human anti-RNP sera contain both human-specific and cross-reactive anti-70K autoantibodies.
    Henriksson EW; Pettersson I
    J Autoimmun; 1996 Aug; 9(4):551-9. PubMed ID: 8864832
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial cell-binding activity of anti-U1-ribonucleoprotein antibodies in patients with connective tissue diseases.
    Okawa-Takatsuji M; Aotsuka S; Uwatoko S; Takaono M; Iwasaki K; Kinoshita M; Sumiya M
    Clin Exp Immunol; 2001 Nov; 126(2):345-54. PubMed ID: 11703381
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autoantibodies in the pathogenesis of mixed connective tissue disease.
    Greidinger EL; Hoffman RW
    Rheum Dis Clin North Am; 2005 Aug; 31(3):437-50, vi. PubMed ID: 16084317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical manifestations and anti-(U1)snRNP antibodies: a prospective study of 29 anti-RNP antibody positive patients.
    Lundberg I; Nyman U; Pettersson I; Hedfors E
    Br J Rheumatol; 1992 Dec; 31(12):811-7. PubMed ID: 1458287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differentiation of RNP- and SM-antibody subsets in SLE and MCTD patients by a new ELISA using recombinant antigens.
    Gaubitz M; Wegmann C; Schotte H; Willeke P; Domschke W
    Cell Mol Biol (Noisy-le-grand); 2002 May; 48(3):317-21. PubMed ID: 12030437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibody penetration of viable human cells. II. Anti-RNP antibodies binding to RNP antigen expressed on cell surface, which may mediate the antibody internalization.
    Ma J; King N; Chen SL; Penny R; Breit SN
    Clin Exp Immunol; 1993 Sep; 93(3):396-404. PubMed ID: 8370166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Anti-U1-RNP antibody and anti-U2-RNP antibody].
    Tojo T; Akiya K
    Nihon Rinsho; 1999 Nov; 57 Suppl():439-42. PubMed ID: 10635877
    [No Abstract]   [Full Text] [Related]  

  • 20. Sequential priming and boosting with heterologous HIV immunogens predominantly stimulated T cell immunity against conserved epitopes.
    Xu J; Ren L; Huang X; Qiu C; Liu Y; Liu Y; Shao Y
    AIDS; 2006 Nov; 20(18):2293-303. PubMed ID: 17117015
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.